Tetramerization of PKM2 can reverse liver fibrosis, and inducing tetramerization of PKM2 to reduce the level of PKM2 dimer may be a potential therapeutic strategy for liver fibrosis (Satyanarayana et al., 2021). Here, PKM is linked to Hepatic fibrosis.